These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12326)

  • 1. Influence of magnesium stearate on the dissolution and biological availability of sulphadiazine tablet formulations [proceedings].
    Ahmed M; Enever RP
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():5P. PubMed ID: 12326
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of magnesium stearate on physical properties and biological availability of sulphadiazine tablet formulations.
    Ahmed M; Enever RP
    Pharm Acta Helv; 1978; 53(12):358-64. PubMed ID: 746045
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of two lubricants (magnesium stearate and pruv) in the formation of tablets of four anti-ulcer agents/ by means of direct compression].
    Garcia Marquez MA; Muñoz A; Jiménez-Castellanos MR
    Pharm Acta Helv; 1992; 67(2):50-6. PubMed ID: 1631172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of tablet disintegrants and magnesium stearate during mixing. II. Effect on dissolution rate.
    Lerk CF; Bolhuis GK; Smallenbroek AJ; Zuurman K
    Pharm Acta Helv; 1982; 57(10-11):282-6. PubMed ID: 7146030
    [No Abstract]   [Full Text] [Related]  

  • 5. Functionality of magnesium stearate derived from bovine and vegetable sources: dry granulated tablets.
    Hamad ML; Gupta A; Shah RB; Lyon RC; Sayeed VA; Khan MA
    J Pharm Sci; 2008 Dec; 97(12):5328-40. PubMed ID: 18351597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delay effect of magnesium stearate on tablet dissolution in acidic medium.
    Ariyasu A; Hattori Y; Otsuka M
    Int J Pharm; 2016 Sep; 511(2):757-64. PubMed ID: 27444551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalency studies on tablet formulation of tetroxoprim and sulphadiazine.
    Alkaysi HN; Salem MA; Gharaibeh AM; Gharaibeh KI; Badwan AA
    J Clin Pharm Ther; 1992 Apr; 17(2):97-9. PubMed ID: 1583085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 5: Effects of lubricants and flow conditions.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jun; 30(6):378-82. PubMed ID: 169527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: The effect of formulation on the availability of sulphadiazine.
    Garnham JC; Raymond K; Shotton E; Turner P
    J Pharm Pharmacol; 1973 Dec; 25():Suppl:151P-152. PubMed ID: 4150557
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of mixing on the biopharmaceutical properties of sulfadiazine tablets.
    Morasso MI; Salas J; Arancibia A
    Farmaco Prat; 1988 May; 43(5):177-88. PubMed ID: 3181415
    [No Abstract]   [Full Text] [Related]  

  • 11. [In vitro and in vivo investigations with different nitrofurantoin formulations (author's transl)].
    Gladigau V; Gebhardt U
    Arzneimittelforschung; 1978; 28(10):1771-8. PubMed ID: 582682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid quantitative analysis of magnesium stearate in pharmaceutical powders and solid dosage forms by atomic absorption: method development and application in product manufacturing.
    Sugisawa K; Kaneko T; Sago T; Sato T
    J Pharm Biomed Anal; 2009 Apr; 49(3):858-61. PubMed ID: 19195812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of the addition of aluminium stearate and of colloidal silica on the properties of rectal suppositories formulations (author's transl)].
    Moës A
    J Pharm Belg; 1976; 31(4):355-66. PubMed ID: 185351
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioavailability of sulfadiazine solutions, suspensions, and tablets in humans.
    Meyer MC; Straughn AB; Ramachander G; Cavagnol JC; Biola Mabadeje AF
    J Pharm Sci; 1978 Dec; 67(12):1659-61. PubMed ID: 581498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution and disintegration characteristics of some experimental formulations of phenindione tablets. 1. Before storage.
    Khalil SH; Ali LM; Abdel-Khalek MM
    Pharmazie; 1973 Oct; 28(10):659-61. PubMed ID: 4783550
    [No Abstract]   [Full Text] [Related]  

  • 17. Lubricity measurements of magnesium stearate [proceedings].
    Moody G; Rubinstein MH; FitzSimmons RA
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():71P. PubMed ID: 42749
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of surfactant-treated starch on the disintegration and dissolution of sulphadiazine tablets.
    Nasipuri RN; Omotosho JA
    J Pharm Pharmacol; 1985 Mar; 37(3):212-3. PubMed ID: 2858573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model for short term drug absorption studies; comparison of sulphadiazine tablets.
    Saunders L; Ahmed M; Enever RP; Natunen T
    J Pharm Pharmacol; 1978 Jan; 30(1):11-4. PubMed ID: 22718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.